Mainz enrols first subject in study to evaluate colorectal cancer test
Mainz Biomed has enrolled the first subject in its eAArly DETECT 2 feasibility study, aimed at evaluating the company's colorectal…
Mainz Biomed has enrolled the first subject in its eAArly DETECT 2 feasibility study, aimed at evaluating the company's colorectal…
GE HealthCare has introduced the latest Invenia Automated Breast Ultrasound (ABUS) Premium to expedite scanning while driving early detection of…
Leadoptik has entered a research partnership with Stanford Medicine, focusing on AI-enhanced real-time optical imaging usage in lung cancer biopsy.…
Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) test, which aims to…
Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent. Illuccix claims to…
Give your business an edge with our leading industry insights.
Australia’s Therapeutic Goods Administration (TGA) has approved Body Vision Medical’s AI-powered advanced imaging system, LungVision, intended to improve the early…
A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ductal adenocarcinoma (PDAC),…
Lynx Dx has commercially launched MyProstateScore 2.0 (MPS2), a urine test kit for prostate cancer intended for at-home sample collection…
A team from the University of Hong Kong (HKU) has developed an AI-driven imaging tool, Cyto-Morphology Adversarial Distillation (CytoMAD), which…
Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare providers in…